ARCHIVES

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

This article is from The Cancer Letter archive.

Vol. 09 No. 09 | March 4, 1983

Download PDF Visit The Full Archive

Related Articles

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

Southwest Oncology Group Becomes “SWOG”

April 8, 2011

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005